首页> 外文期刊>Cytometry, Part B. Clinical cytometry: the journal of the International Society for Analytical Cytology >Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood
【24h】

Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood

机译:免疫磁性细胞富集结合RT-PCR在检测人外周血中罕见的循环头颈部肿瘤细胞中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Detection of rare, circulating tumor cells (CTC's) in human peripheral blood is a potential indicator of prognosis and diagnosis in oncology. Typical methods to detect these CTC's are either by immunocytochemistry (ICCS) or RT-PCR. However without accurate, rapid, and reproducible enrichment processes, these detection techniques are labor intensive and/or unreliable. In this article, a repeatable enrichment process that included a flow-through immunomagnetic cell separation system, the quadrupole magnetic sorter (QMS) was optimized with the aid of a statistical analysis software package. The QMS was operated in a negative mode of operation by immunomagnetically targeting normal human peripheral blood lymphocytes (PBL) through the C045 surface marker. Three head and neck squamous carcinoma cell lines (HNSCC), Detroit-562, SCIG-4, and CAL-27, were used to determine the sensitivity of RT-PCR for the epidermal growth factor receptor (EGFR) in spiked PBL. The detection purity needed for detection was found to be one cell in 104, one cell in 103, and one cell in 105 for the Detroit-562; SCC-4, and CAL-27, respectively. The actual number of cancer cells needed for RT-PCR detection ranged from 30 to 1 cell. To mimic the potential concentration of rare CTC present in peripheral blood of cancer patients, the spiking concentration was chosen to be one cancer cell per 105 total leukocytes from healthy donors. Using a single step immunomagnetic labeling, the final, optimized enrichment process produced a 57.6 +/- 30.3-fold (n = 6) enrichment of the rare cancer cells with a final cancer cell recovery of (77.8 +/- 6.6)%. (c) 2007 Clinical Cytornetry Society.
机译:检测人外周血中稀有的循环肿瘤细胞(CTC)是肿瘤学预后和诊断的潜在指标。检测这些CTC的典型方法是通过免疫细胞化学(ICCS)或RT-PCR。但是,如果没有准确,快速和可再现的富集过程,这些检测技术将需要大量劳动和/或不可靠。在本文中,可重复的富集过程包括流通式免疫磁性细胞分离系统,四极磁性分选仪(QMS)借助统计分析软件包进行了优化。通过通过C045表面标记免疫磁性靶向正常人外周血淋巴细胞(PBL),以负操作模式操作QMS。三种头颈部鳞状细胞癌细胞系(HNSCC),底特律562,SCIG-4和CAL-27用于确定加标PBL中RT-PCR对表皮生长因子受体(EGFR)的敏感性。对于底特律562,检测所需的检测纯度为104个细胞,103个细胞和105个细胞。 SCC-4和CAL-27。 RT-PCR检测所需的实际癌细胞数为30至1个细胞。为了模拟癌症患者外周血中稀有CTC的潜在浓度,将加标浓度选择为来自健康供体的105个总白细胞中一个癌细胞。使用一步免疫磁标记,最终的优化富集过程产生了稀有癌细胞57.6 +/- 30.3倍(n = 6)的富集,最终癌细胞回收率为(77.8 +/- 6.6)%。 (c)2007临床椎体学会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号